Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research-Anti-Infectives

Volume 8

eBook: US $79 Special Offer (PDF + Printed Copy): US $145
Printed Copy: US $105
Library License: US $316
ISSN: 2452-3208 (Print)
ISSN: 2352-3212 (Online)
ISBN: 978-981-5039-42-9 (Print)
ISBN: 978-981-5039-41-2 (Online)
Year of Publication: 2021
DOI: 10.2174/97898150394121210801

Introduction

Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.

The eighth volume of this series presents comprehensive reviews of interest to readers interested in the treatment of inflammatory diseases, new antiviral agents and strategies, specific antiprotozoal drugs that work against leishmania and helminths, and a study on potential agents against American foulbrood in honey bees. The 7 reviews included in this volume are:

- Monoclonal antibodies as therapeutic agents for inflammatory diseases

- Pharmacotherapy of emerging antiviral agents

- Antiviral activity of vitamin D and COVID-19: current understanding

- Anti-infectives to combat leishmaniasis

- Anthelmintic drug discovery: current situation and future perspectives

- Therapeutic targets for emerging Zika virus infection and vaccines in clinical trials

- Agro-industrial waste: new source of raw material for the control of American foulbrood in honey bees

Audience: Pharmaceutical scientists, medical doctors, virologists, entomologists, epidemiologists

Contributors

Editor(s):
Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Aytül Gül
Bioengineering, Faculty of Engineering
Ege University
İzmir
Turkey


Ahmet Efe Köseoğlu
Biology, Faculty of Science
Ege University
İzmir
Turkey


Aysu Değirmenci Döşkaya
Parasitology, Faculty of Medicine
Ege University
İzmir
Turkey


Adnan Yüksel Gürüz
Parasitology, Faculty of Medicine
Ege University
İzmir
Turkey


Bakulesh Khamar
Cadila Pharmaceuticals Limited
Gujarat University
Ahmedabad, Gujarat
India


Bibha Choudhary
Bioinformatics and Applied Biotechnology
Bengaluru
India


Ceren Gül
Biotechnology
Ege University
İzmir
Turkey


Cemal Ün
Bioengineering, Faculty of Engineering
Ege University
İzmir
Turkey


Chandreshwar Shukla
Life Science Department
Gujarat University
Ahmedabad, Gujarat
India


Daniel Liu
Clinical Service Center
Beijing
China


Hualong Sun
Clinical Service Center
Beijing
China


Hüseyin Can
Biology, Faculty of Science
Ege University
İzmir
Turkey
/
Biology, Faculty of Science
Ege University
İzmir
Turkey


Ilgiz Gareev
Bashkir State Medical University
Ufa, Republic of Bashkortostan
Russia


Joey Wang
Meta Clinical Data Technology, Inc
Beijing
China


Kexun Lian
Animal Science and Technology
Shihezi University
Xinjiang
China


Levent Yeniay
General Surgery
Ege University
İzmir
Turkey


Maryam Zanjirband
Cell and Molecular Biology & Microbiology
Biological Science and Technology, University of Isfahan
Isfahan
Iran


Meghana Manjunath
Bioinformatics and Applied Biotechnology
Bengaluru
India


Muhammet Karakavuk
Ödemiş Technical Training College
Ege University
İzmir
Turkey


Mert Döşkaya
Parasitology, Faculty of Medicine
Ege University
İzmir
Turkey


Mengmeng Wang
Animal Science and Technology
Shihezi University
Xinjiang
China


Nayan K Jain
Life Science Department
Gujarat University
Ahmedabad, Gujarat
India


Ozal Beylerli
Bashkir State Medical University
Ufa, Republic of Bashkortostan
Russia


Sedef Erkunt Alak
Molecular Biology, Faculty of Science
Ege University
İzmir
Turkey


Tuğba Karakavuk
Biotechnology
Ege University
İzmir
Turkey


Xiaoyan Hu
Biomedicine and Biotechnology
Bengaluru
India


Xun Zhang
Biomedical Engineering
Southern University of Science and Technology
Guangdong
China


Yan Bo
Meta Clinical Data Technology, Inc
Beijing
China